Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirong Peng

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal for Immunotherapy of Cancer|August 21, 2021
B7 score and T cell infiltration stratify immune status in prostate cancerQianghua Zhou, Kaiwen Li, Yiming Lai, et al.
Cell Death & Disease|February 23, 2026
PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancerRuilin Zhuang, Qianghua Zhou, Bisheng Cheng, et al.
Clinical and Translational Medicine|November 2, 2020
The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signalingZean Li, Qiong Wang, Shirong Peng, et al.
Aging|May 28, 2020
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathwayKaiwen Li, Shirong Peng, Zean Li, et al.
Neuro-Oncology|January 13, 2026
ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: a single-arm, phase 1/2 studyWei Zeng, Peiwen Wang, Sheng Fang, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal for Immunotherapy of Cancer|August 21, 2021
B7 score and T cell infiltration stratify immune status in prostate cancerQianghua Zhou, Kaiwen Li, Yiming Lai, et al.
Cell Death & Disease|February 23, 2026
PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancerRuilin Zhuang, Qianghua Zhou, Bisheng Cheng, et al.
Clinical and Translational Medicine|November 2, 2020
The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signalingZean Li, Qiong Wang, Shirong Peng, et al.
Aging|May 28, 2020
Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathwayKaiwen Li, Shirong Peng, Zean Li, et al.
Neuro-Oncology|January 13, 2026
ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: a single-arm, phase 1/2 studyWei Zeng, Peiwen Wang, Sheng Fang, et al.
Pageof 3